Cytokinetics, Incorporated(NASDAQ:CYTK) 
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is developing small molecule drug candidates primarily engineered to increase mu...
Website: http://www.cytokinetics.com
Founded: 1997
Full Time Employees: 156
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 40.44
H 40.62
L 36.89
C 37.36
V 3,208,673
10EMA 37.36
20EMA 37.36
60EMA 37.36
120EMA 37.36
250EMA 37.36